Balyasny Asset Management
VECT

Balyasny Asset Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Balyasny Asset Management’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-322,418
Closed -$2.77M – 3117
2023
Q1 		$2.77M Sell
322,418
-20,866
-6% -$172K 0.01% 1330
2022
Q4 		$2.96M Sell
343,284
-19,254
-5% -$155K 0.01% 1251
2022
Q3 		$2.17M Sell
362,538
-2,994
-0.8% -$16.3K 0.01% 1446
2022
Q2 		$1.97M Buy
+365,532
New +$1.97M 0.01% 1406

Other funds holding VECT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management's VECT Position: Q2 2023 in Review

Balyasny Asset Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 322,418 shares — an estimated $2.77M sold.

Balyasny Asset Management first reported a position in VECT in Q2 2022 and held it in 4 quarters. The position peaked at $2.96M in Q4 2022. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

  • Balyasny Asset Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 322,418 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $2.77M.
  • Balyasny Asset Management first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2022 and held it in 4 quarters.
  • Balyasny Asset Management's VectivBio Holding AG Ordinary Shares position peaked at $2.96M in Q4 2022.
  • 49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.